Advertisment

Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:1077

Official publication of the Indian Society of Nephrology
  ~   Site Statistics 
  ~   Addresses 
  ~   Search 
  ~   My Preferences 
  ~   Online Submission 

 


This article has been cited by
1Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula
Te-I. Chang,Cheng-Hsien Chen,Hui-Ling Hsieh,Chun-You Chen,Shih-Chang Hsu,Ho-Shun Cheng,Wen-Cheng Huang,Yuh-Mou Sue,Yung-Ho Hsu,Feng-Yen Lin,Chun-Ming Shih,Shing-Jong Lin,Po-Hsun Huang,Chung-Te Liu
Scientific Reports.2020;10(1)
[DOI]
2Antithrombotic medications in dialysis patients: a double-edged sword
Georgios Vlachopanos,Farid Girgis Ghalli
Journal of Evidence-Based Medicine.2017;10(1)53
[DOI]
3Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study
P. Y. Fan,C. C. Lee,S. H. Liu,I.-J. Li,C. H. Weng,K. H. Tu,M. Y. Hsieh,C. F. Kuo,T.-Y. Chang,Y. C. Tian,C. W. Yang,H. H. Wu
Journal of Thrombosis and Haemostasis.2019;17(1)77
[DOI]
4Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study
Felicitas L. Koller,Kenneth J. Woodside
Journal of Thrombosis and Haemostasis.2017;17(1)87
[DOI]
5Editor's Choice – Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
Jürg Schmidli,Matthias K. Widmer,Carlo Basile,Gianmarco de Donato,Maurizio Gallieni,Christopher P. Gibbons,Patrick Haage,George Hamilton,Ulf Hedin,Lars Kamper,Miltos K. Lazarides,Ben Lindsey,Gaspar Mestres,Marisa Pegoraro,Joy Roy,Carlo Setacci,David Shemesh,Jan H.M. Tordoir,Magda van Loon,Magda ESVS Guidelines Committee,Philippe Kolh,Gert J. de Borst,Nabil Chakfe,Sebastian Debus,Rob Hinchliffe,Stavros Kakkos,Igor Koncar,Jes Lindholt,Ross Naylor,Melina Vega de Ceniga,Frank Vermassen,Fabio Verzini,Fabio ESVS Guidelines Reviewers,Markus Mohaupt,Jean-Baptiste Ricco,Ramon Roca-Tey
European Journal of Vascular and Endovascular Surgery.2018;55(6)757
[DOI]
6Editor's Choice – Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
Suetonia C Palmer,Lucia Di Micco,Mona Razavian,Jonathan C Craig,Vlado Perkovic,Fabio Pellegrini,Meg J Jardine,Angela C Webster,Sophia Zoungas,Giovanni FM Strippoli,Suetonia C Palmer
European Journal of Vascular and Endovascular Surgery.2013;55(6)757
[DOI]
7Editor's Choice – Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
Rebecca Hudson,David Johnson,Andrea Viecelli
European Journal of Vascular and Endovascular Surgery.2019;55(6)757
[DOI]
8Pharmaceutical prevention strategy for arteriovenous fistula and arteriovenous graft failure
Hiroyuki Tsukada,Motonobu Nakamura,Tomohito Mizuno,Nobuhiko Satoh,Masaomi Nangaku
Renal Replacement Therapy.2019;5(1)757
[DOI]
9Should Patients be on Antithrombotic Medication for their First Arteriovenous Fistulae?
Alexander Murley,Anika Wijewardane,Teun Wilmink,Jyoti Baharani
The Journal of Vascular Access.2016;17(2)118
[DOI]
10Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts
Imran Mohamed,Mohamad Fathul Aizat Kamarizan,Antonio Da Silva
Cochrane Database of Systematic Reviews.2021;2021(7)118
[DOI]
11Effect of antiplatelet therapy on cardiovascular and kidney outcomes in patients with chronic kidney disease: a systematic review and meta-analysis
Xiaole Su,Bingjuan Yan,Lihua Wang,Jicheng Lv,Hong Cheng,Yipu Chen
BMC Nephrology.2019;20(1)118
[DOI]
12A multicentre analysis of the outcome of arteriovenous fistula in maintenance haemodialysis
Swathi Jothi,Hareesh KG,Nancy Lesley,Madhusudan Vijayan,Sneha Haridas Anupama,Milly Mathew,Rajeevalochana Parthasarathy,Saravanan Sundarajan,Nagarajan P,Latha Kumaraswamy,Georgi Abraham
Seminars in Dialysis.2020;33(5)388
[DOI]
13A Meta-analysis of the Impact of Aspirin, Clopidogrel, and Dual Antiplatelet Therapy on Bleeding Complications in Noncardiac Surgery
Jesse A. Columbo,Andrew J. Lambour,Rebecca A. Sundling,Nirali B. Chauhan,Sarah Y. Bessen,David L. Linshaw,Ravinder Kang,Natalie B. V. Riblet,Philip P. Goodney,David H. Stone
Annals of Surgery.2018;267(1)1
[DOI]
14Beraprost sodium versus clopidogrel for preventing vascular thromboembolic events of arteriovenous fistula in uraemic patients: a retrospective study with a mean 3-year follow-up
Ziming Wan,Ying Zhu,Ruikun Yang,Yongjian Zhang,Chen Yang,Lei Cao,Wenjing Yan,Qi Wang,Ning Li,Mingdong Zhao,Keke Gui,Min Xiong
Journal of International Medical Research.2019;47(1)252
[DOI]
15Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study
Yoojin Noh,Jimin Lee,Sooyoung Shin,Inwhee Park,Soo Kyung Bae,Euichul Oh,Sukhyang Lee
International Journal of Clinical Pharmacy.2018;40(1)160
[DOI]
16Antiplatelet Therapy to Prevent Hemodialysis Vascular Access Failure: Systematic Review and Meta-analysis
Suetonia C. Palmer,Lucia Di Micco,Mona Razavian,Jonathan C. Craig,Pietro Ravani,Vlado Perkovic,Gianni Tognoni,Giusi Graziano,Meg Jardine,Fabio Pellegrini,Antonio Nicolucci,Angela Webster,Giovanni F.M. Strippoli
American Journal of Kidney Diseases.2013;61(1)112
[DOI]
17Role of antiplatelet therapy in the durability of hemodialysis access
Satinderjit Locham,Robert J. Beaulieu,Hanaa Dakour-Aridi,Besma Nejim,Mahmoud B. Malas
Journal of Nephrology.2018;31(4)603
[DOI]
18Clopidogrel Use in End-Stage Kidney Disease
Bassem Y. Tanios,Houssam S. Itani,Deborah L. Zimmerman
Seminars in Dialysis.2015;28(3)276
[DOI]
19Maintenance of Hemodialysis Vascular Access and Prevention of Access Dysfunction: A Review
Matthew Thomas,Craig Nesbitt,Maaz Ghouri,Monica Hansrani
Annals of Vascular Surgery.2017;43(3)318
[DOI]
20The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled
Andrea K Viecelli,Trevor A Mori,Prabir Roy-Chaudhury,Kevan R Polkinghorne,Carmel M Hawley,David W Johnson,Elaine M Pascoe,Ashley B Irish
Seminars in Dialysis.2018;31(3)244
[DOI]
21KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
Charmaine E. Lok,Thomas S. Huber,Timmy Lee,Surendra Shenoy,Alexander S. Yevzlin,Kenneth Abreo,Michael Allon,Arif Asif,Brad C. Astor,Marc H. Glickman,Janet Graham,Louise M. Moist,Dheeraj K. Rajan,Cynthia Roberts,Tushar J. Vachharajani,Rudolph P. Valentini
American Journal of Kidney Diseases.2020;75(4)S1
[DOI]
22Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement
Rubie Sue Jackson,Anton N. Sidawy,Richard L. Amdur,Akhil Khetarpal,Robyn A. Macsata
Journal of Vascular Surgery.2011;54(6)1706
[DOI]
23Patients on Hemodialysis Are Better Served by a Proximal Arteriovenous Fistula for Long-Term Venous Access
Sherif Sultan,Niamh Hynes,Nader Hamada,Wael Tawfick
Vascular and Endovascular Surgery.2012;46(8)624
[DOI]
24Medical Adjuvant Treatment to Improve the Patency of Arteriovenous Fistulae and Grafts: A Systematic Review and Meta-analysis
N.C. Tanner,A.F. da Silva
European Journal of Vascular and Endovascular Surgery.2016;52(2)243
[DOI]
25Medical Adjuvant Treatment to Improve the Patency of Arteriovenous Fistulae and Grafts: A Systematic Review and Meta-analysis
Suetonia C Palmer,Lucia Di Micco,Mona Razavian,Jonathan C Craig,Vlado Perkovic,Fabio Pellegrini,Meg J Jardine,Angela C Webster,Sophia Zoungas,Giovanni FM Strippoli,Suetonia C Palmer
European Journal of Vascular and Endovascular Surgery.2013;52(2)243
[DOI]
26Effect of Antiplatelet Agents, Statins, and Other Drugs on Vascular Access Patency Rates
Kosmas I. Paraskevas,Dimitri P. Mikhailidis,Nikolaos Roussas,Athanasios D. Giannoukas
Angiology.2012;63(1)5
[DOI]
© Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07